Clinical Genomic Interpretation Service
Other
≈ ¥200-500
(≈ $30-70)
2 hr
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
Estimated cost for Clinical Genomic Interpretation Service at general public hospitals in China is about ¥140-400, and at Grade 3A hospitals about ¥200-500, varying by hospital tier and region.
Main Uses
This fee covers the professional clinical interpretation of raw or analyzed genetic test data by qualified healthcare providers (e.g., certified genetic counselors, clinical molecular geneticists, or medical geneticists). Primary uses include translating variant classifications (e.g., pathogenic, VUS, benign) into patient-specific risk assessments; correlating findings with personal/family history; guiding diagnosis, surveillance, treatment (e.g., targeted therapy eligibility), reproductive planning, and cascade testing; generating structured, actionable reports compliant with ACMG/AMP guidelines; and supporting informed consent and post-test counseling.
Normal Range
Not applicable — 'Clinical Interpretation Fee for Genetic Testing Report' is a billing service charge, not a biological laboratory measurement. It has no physiological normal range, reference intervals, or numerical values. The fee varies by institution, test complexity, and clinical context (e.g., $150–$600 USD), but this is an administrative cost, not a biomarker.
Low Values - Possible Causes
N/A — This is a service fee, not a clinical biomarker; 'low' values do not reflect a biological condition. A lower-than-expected fee may result from institutional pricing tiers, insurance negotiation, government-subsidized programs, simplified interpretation scope, or bundled testing packages.
High Values - Possible Causes
N/A — As a non-biological service charge, 'high' values are not clinically meaningful. Elevated fees may stem from comprehensive multi-gene panel interpretation, involvement of board-certified clinical molecular geneticists, urgent turnaround time (<5 business days), inclusion of familial risk assessment and counseling documentation, or integration with electronic health record (EHR) systems and regulatory reporting (e.g., CLIA/CAP compliance).